Ovid Therapeutics (OVID) Earnings Date & Reports

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

OVID is expected to report earnings to fall 24.17% to -9 cents per share on November 11

Ovid Therapeutics OVID Stock Earnings Reports

Q3'26

Est.

$-0.09

Q1'26

Est.

$-0.12

Q4'25

Beat

by $0.17

Q3'25

Missed

by $0.02

Q2'25

Beat

by $0.10

The last earnings report on May 12 showed earnings per share of -11 cents, meeting the estimate of -11 cents. With 788.92K shares outstanding, the current market capitalization sits at 546.83M.

View a ticker or compare two or three

OVID

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days